Concept Architecture
Concept
Theoretically, Steady State is the pharmacokinetic condition in which the rate of drug administration equals the rate of drug elimination, resulting in a stable average drug concentration within the body despite ongoing fluctuations between dosing intervals. The concept is founded on mass balance principles and first-order pharmacokinetics and exists to describe the equilibrium achieved during repeated dosing or continuous infusion. Steady state is fundamental to optimising dosing regimens and maintaining therapeutic drug concentrations.
Mathematically, steady state is reached asymptotically during repeated drug administration. Under first-order elimination, the average steady-state concentration depends on the dosing rate and systemic clearance, while the time required to reach steady state depends solely on the elimination half-life. For most drugs exhibiting linear pharmacokinetics, steady state is effectively achieved after approximately four to five elimination half-lives.
In practice, steady state is estimated using pharmacokinetic models, therapeutic drug monitoring and concentration-time data collected after repeated dosing. It is routinely considered when designing clinical trials, selecting maintenance doses and interpreting plasma drug concentrations. In health economics, steady-state assumptions influence estimates of treatment effectiveness, adverse event profiles, medication adherence, dosing frequency, healthcare resource utilisation and pharmaceutical costs within economic evaluation models.
Purpose
Used to determine when repeated drug administration produces stable systemic drug exposure, supporting dose optimisation, therapeutic monitoring and pharmacoeconomic evaluation of pharmaceutical therapies.
Mathematical Formulae
Primary Formula
C?ss = (F ? Dose) / (CL ? �)
Supporting Formulae
Continuous infusion:
Css = R? / CL
Accumulation factor:
R = 1 / (1 ? e???)
Time to steady state:
tss � 4?5 ? t�
Elimination half-life:
t� = ln(2) / k
Related Mathematical Methods
- Pharmacokinetics
- First-Order Kinetics
- Compartmental Analysis
- Population Pharmacokinetic Modelling
- Therapeutic Drug Monitoring
- Nonlinear Regression
Example
A medicine is administered orally once daily.
Bioavailability (F) = 1.0
Dose = 200 mg
Clearance (CL) = 5 L/hour
Dosing interval (�) = 24 hours
Average steady-state concentration:
C?ss = (1.0 ? 200) � (5 ? 24)
C?ss = 1.67 mg/L
If the elimination half-life is 12 hours, steady state is expected after approximately:
tss � 5 ? 12 = 60 hours
Excel Implementation
| Function | Example Formula | Health Economics Application |
|---|---|---|
| EXP | =EXP(-k*Tau) | Calculates accumulation factors. |
| LN | =LN(2)/k | Calculates elimination half-life. |
| PMT | =(Bioavailability*Dose)/(Clearance*Interval) | Calculates average steady-state concentration. |
| POWER | =(1/2)^(Time/HalfLife) | Estimates progression towards steady state. |
| IF | =IF(Time>=5*HalfLife,"Approximate steady state","Not yet") | Determines whether steady state has likely been reached. |
VBA (Optional)
VBA can automate repeated-dose pharmacokinetic simulations to estimate steady-state concentrations and evaluate alternative dosing regimens.
Sources
- Rowland M, Tozer TN. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications.
- Gibaldi M, Perrier D. Pharmacokinetics.
- Gabrielsson J, Weiner D. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications.
- Ette EI, Williams PJ. Pharmacokinetics in Drug Development.
- Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation.
- Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes.
Related Concepts (2)
Library
Publications
1
Pharmacoeconomics: From Theory to Practice — Renee J. G. Arnold (ed.), 2nd Edition ed., 2021 (CRC Press (Routledge))
An applied, practitioner-oriented pharmacoeconomics reference covering decision modelling, cost of illness, Markov modelling, retrospective database analysis, budget impact, multi-criteria decision analysis, value-based pricing of pharmaceuticals, and reimbursement, with real-world examples.
BookView source →
Frequently Asked Questions (6)
What is steady state?
A pharmacokinetic condition where a drug's concentration remains stable because the rate of administration equals the rate of elimination.
Source: Rowland & Tozer 2010
What balance defines steady state?
Steady state is the condition in which a drug's concentration in the body stays stable because the rate at which it is given exactly matches the rate at which it is eliminated. Reached after repeated regular doses, it is the point where the amount entering and leaving the body balance, so the concentration no longer drifts up or down. It matters because a drug's full and consistent effect is usually seen only once steady state is reached, which takes several half-lives. A balance of intake and elimination is what defines it. Rowland and Tozer (2010) describe this.
Source: Rowland & Tozer 2010
How is steady state reached?
Steady state is reached through repeated dosing, as the drug accumulates until the amount eliminated between doses equals the amount administered; this typically takes about four to five half-lives of the drug, after which the concentration is close to steady state. So steady state is reached over several half-lives of regular dosing, which is why drugs with long half-lives take longer to reach it, since accumulation to the stable level occurs over multiples of the half-life, and this is relevant for knowing when a drug's full and consistent effect will be achieved and whether a loading dose is needed to reach it sooner.
Source: Rowland & Tozer 2010
Why does steady state matter?
Steady state matters because it represents the stable drug concentration achieved with ongoing dosing, at which the drug's effect is generally most consistent, so knowing when it is reached indicates when the full, steady therapeutic effect can be expected. So steady state is important for understanding and timing drug therapy, which is why it is a key concept, since dosing is often designed to achieve and maintain steady-state concentrations in the therapeutic range, and the time to reach steady state, determined by the half-life, tells clinicians when the drug's stable effect will be established and when to assess response or measure levels.
Source: Rowland & Tozer 2010
How does half-life relate to steady state?
Half-life relates to steady state because the time to reach steady state depends on the half-life, with the drug approaching steady state after about four to five half-lives of regular dosing; a longer half-life means a longer time to reach steady state. So the half-life determines how quickly steady state is achieved, which is why long-half-life drugs take longer, since the accumulation to a stable level occurs over multiples of the half-life, and this relationship explains why a loading dose may be used for long-half-life drugs to reach the therapeutic level quickly rather than waiting several half-lives for steady state.
Source: Rowland & Tozer 2010
How is steady state used in dosing?
Steady state is used in dosing by designing regimens to achieve and maintain a steady-state concentration within the therapeutic range, and by timing the assessment of drug levels, since measurements are often most meaningful once steady state is reached. So steady state guides dosing and monitoring, which is why regular dosing aims to reach a therapeutic steady-state level and why drug level measurements are typically taken at steady state, since the stable concentration reflects the ongoing therapeutic exposure, and understanding steady state helps in setting doses, interpreting levels, and deciding when a loading dose is needed to reach the target sooner.
Source: Rowland & Tozer 2010
Trust Record
Verified by Dr Darrin Baines
British health economist
Professional identity: darrinbaines.org
Verification date: 17 Apr 2026
Content version: 1.0.0
Canonical Identity
- Persistent URI
- https://healtheconomics.wiki/concept/steady-state
- Term code
- HE-PE-CP-014
Stable URI · Machine-readable · Resolvable · CC BY 4.0